1 Study Coverage
1.1 Lung Cancer Liquid Biopsy Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Lung Cancer Liquid Biopsy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Lung Cancer Liquid Biopsy Market Size for the Year 2017-2028
1.2.2 Global Lung Cancer Liquid Biopsy Market Size for the Year 2017-2028
1.3 Lung Cancer Liquid Biopsy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Lung Cancer Liquid Biopsy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Lung Cancer Liquid Biopsy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Lung Cancer Liquid Biopsy Market Dynamics
1.4.1 Lung Cancer Liquid Biopsy Industry Trends
1.4.2 Lung Cancer Liquid Biopsy Market Drivers
1.4.3 Lung Cancer Liquid Biopsy Market Challenges
1.4.4 Lung Cancer Liquid Biopsy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Lung Cancer Liquid Biopsy by Type
2.1 Lung Cancer Liquid Biopsy Market Segment by Type
2.1.1 Exosomes and RNA
2.1.2 CTCs and ctDNA
2.2 Global Lung Cancer Liquid Biopsy Market Size by Type (2017, 2022 & 2028)
2.3 Global Lung Cancer Liquid Biopsy Market Size by Type (2017-2028)
2.4 United States Lung Cancer Liquid Biopsy Market Size by Type (2017, 2022 & 2028)
2.5 United States Lung Cancer Liquid Biopsy Market Size by Type (2017-2028)
3 Lung Cancer Liquid Biopsy by Application
3.1 Lung Cancer Liquid Biopsy Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Lung Cancer Liquid Biopsy Market Size by Application (2017, 2022 & 2028)
3.3 Global Lung Cancer Liquid Biopsy Market Size by Application (2017-2028)
3.4 United States Lung Cancer Liquid Biopsy Market Size by Application (2017, 2022 & 2028)
3.5 United States Lung Cancer Liquid Biopsy Market Size by Application (2017-2028)
4 Global Lung Cancer Liquid Biopsy Competitor Landscape by Company
4.1 Global Lung Cancer Liquid Biopsy Market Size by Company
4.1.1 Top Global Lung Cancer Liquid Biopsy Companies Ranked by Revenue (2021)
4.1.2 Global Lung Cancer Liquid Biopsy Revenue by Player (2017-2022)
4.2 Global Lung Cancer Liquid Biopsy Concentration Ratio (CR)
4.2.1 Lung Cancer Liquid Biopsy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Lung Cancer Liquid Biopsy in 2021
4.2.3 Global Lung Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Lung Cancer Liquid Biopsy Headquarters, Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million) Type
4.3.1 Global Lung Cancer Liquid Biopsy Headquarters and Area Served
4.3.2 Global Lung Cancer Liquid Biopsy Companies Revenue in Lung Cancer Liquid Biopsy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Lung Cancer Liquid Biopsy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Lung Cancer Liquid Biopsy Market Size by Company
4.5.1 Top Lung Cancer Liquid Biopsy Players in United States, Ranked by Revenue (2021)
4.5.2 United States Lung Cancer Liquid Biopsy Revenue by Players (2020, 2021 & 2022)
5 Global Lung Cancer Liquid Biopsy Market Size by Region
5.1 Global Lung Cancer Liquid Biopsy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Lung Cancer Liquid Biopsy Market Size by Region (2017-2028)
5.2.1 Global Lung Cancer Liquid Biopsy Market Size by Region: 2017-2022
5.2.2 Global Lung Cancer Liquid Biopsy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Lung Cancer Liquid Biopsy Market Size YoY Growth 2017-2028
6.1.2 North America Lung Cancer Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Lung Cancer Liquid Biopsy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Lung Cancer Liquid Biopsy Market Size YoY Growth 2017-2028
6.3.2 Europe Lung Cancer Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Lung Cancer Liquid Biopsy Market Size YoY Growth 2017-2028
6.4.2 Latin America Lung Cancer Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Lung Cancer Liquid Biopsy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Lung Cancer Liquid Biopsy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 RainDanceTechnologies
7.1.1 RainDanceTechnologies Company Details
7.1.2 RainDanceTechnologies Business Overview
7.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Introduction
7.1.4 RainDanceTechnologies Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.1.5 RainDanceTechnologies Recent Development
7.2 Biocartis
7.2.1 Biocartis Company Details
7.2.2 Biocartis Business Overview
7.2.3 Biocartis Lung Cancer Liquid Biopsy Introduction
7.2.4 Biocartis Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.2.5 Biocartis Recent Development
7.3 Qiagen
7.3.1 Qiagen Company Details
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Lung Cancer Liquid Biopsy Introduction
7.3.4 Qiagen Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.3.5 Qiagen Recent Development
7.4 Guardant Health
7.4.1 Guardant Health Company Details
7.4.2 Guardant Health Business Overview
7.4.3 Guardant Health Lung Cancer Liquid Biopsy Introduction
7.4.4 Guardant Health Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.4.5 Guardant Health Recent Development
7.5 MDxHealth
7.5.1 MDxHealth Company Details
7.5.2 MDxHealth Business Overview
7.5.3 MDxHealth Lung Cancer Liquid Biopsy Introduction
7.5.4 MDxHealth Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.5.5 MDxHealth Recent Development
7.6 Pathway Genomics
7.6.1 Pathway Genomics Company Details
7.6.2 Pathway Genomics Business Overview
7.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Introduction
7.6.4 Pathway Genomics Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.6.5 Pathway Genomics Recent Development
7.7 NeoGenomics Laboraories
7.7.1 NeoGenomics Laboraories Company Details
7.7.2 NeoGenomics Laboraories Business Overview
7.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Introduction
7.7.4 NeoGenomics Laboraories Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.7.5 NeoGenomics Laboraories Recent Development
7.8 Sysmex Inostics
7.8.1 Sysmex Inostics Company Details
7.8.2 Sysmex Inostics Business Overview
7.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Introduction
7.8.4 Sysmex Inostics Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.8.5 Sysmex Inostics Recent Development
7.9 Cynvenio
7.9.1 Cynvenio Company Details
7.9.2 Cynvenio Business Overview
7.9.3 Cynvenio Lung Cancer Liquid Biopsy Introduction
7.9.4 Cynvenio Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.9.5 Cynvenio Recent Development
7.10 Menarini Silicon Biosystems
7.10.1 Menarini Silicon Biosystems Company Details
7.10.2 Menarini Silicon Biosystems Business Overview
7.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Introduction
7.10.4 Menarini Silicon Biosystems Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.10.5 Menarini Silicon Biosystems Recent Development
7.11 Adaptive Biotechnologies
7.11.1 Adaptive Biotechnologies Company Details
7.11.2 Adaptive Biotechnologies Business Overview
7.11.3 Adaptive Biotechnologies Lung Cancer Liquid Biopsy Introduction
7.11.4 Adaptive Biotechnologies Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.11.5 Adaptive Biotechnologies Recent Development
7.12 Biocept
7.12.1 Biocept Company Details
7.12.2 Biocept Business Overview
7.12.3 Biocept Lung Cancer Liquid Biopsy Introduction
7.12.4 Biocept Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.12.5 Biocept Recent Development
7.13 Angle plc
7.13.1 Angle plc Company Details
7.13.2 Angle plc Business Overview
7.13.3 Angle plc Lung Cancer Liquid Biopsy Introduction
7.13.4 Angle plc Revenue in Lung Cancer Liquid Biopsy Business (2017-2022)
7.13.5 Angle plc Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
